Found: 56
Select item for more details and to access through your institution.
Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients?
- Published in:
- 2003
- By:
- Publication type:
- journal article
Assessment of clonality of rosetting T lymphocytes in Hodgkin's disease by single-cell polymerase chain reaction: detection of clonality in a polyclonal background in a case of lymphocyte predominance Hodgkin's disease.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Clinical approaches to vaccination in oncology.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Tumour vaccines: a new immunotherapeutic approach in oncology.
- Published in:
- 2000
- By:
- Publication type:
- journal article
IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group.
- Published in:
- 2000
- By:
- Publication type:
- journal article
STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
- Published in:
- Oncogene, 2008, v. 27, n. 29, p. 4096, doi. 10.1038/onc.2008.40
- By:
- Publication type:
- Article
First manifestations of seronegative spondylarthropathy following autologous stem cell transplantation in HLA-B27-positive patients.
- Published in:
- Bone Marrow Transplantation, 2000, v. 26, n. 6, p. 673, doi. 10.1038/sj.bmt.1702565
- By:
- Publication type:
- Article
Glucagonoma syndrome and bronchial carcinoma.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Self-tolerance of Human Natural Killer Cells Lacking Self-HLA-specific Inhibitory Receptors.
- Published in:
- Scandinavian Journal of Immunology, 2008, v. 67, n. 3, p. 218, doi. 10.1111/j.1365-3083.2007.02058.x
- By:
- Publication type:
- Article
Resistance Against Natural Killer Cell Cytotoxicity: Analysis of Mechanisms.
- Published in:
- Scandinavian Journal of Immunology, 2006, v. 64, n. 4, p. 444, doi. 10.1111/j.1365-3083.2006.01803.x
- By:
- Publication type:
- Article
Obesity negatively impacts outcome in elderly female patients with aggressive B‐cell lymphomas treated with R‐CHOP: results from prospective trials of the German high grade non‐Hodgkin's lymphoma trial group.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 2, p. 236, doi. 10.1111/bjh.15029
- By:
- Publication type:
- Article
Rational Use of Blood and Blood Components in Hematology and Oncology.
- Published in:
- Transfusion Medicine & Hemotherapy, 2000, v. 27, n. 4, p. 190, doi. 10.1159/000025269
- By:
- Publication type:
- Article
The interleukin-10 gene promoter polymorphism −1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma.
- Published in:
- Genes & Immunity, 2007, v. 8, n. 2, p. 164, doi. 10.1038/sj.gene.6364364
- By:
- Publication type:
- Article
Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma: recent results and future prospects.
- Published in:
- Leukemia (08876924), 1997, v. 11, p. S55
- By:
- Publication type:
- Article
CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 11, p. 1521, doi. 10.1007/s00277-013-1880-4
- By:
- Publication type:
- Article
Population Pharmacokinetics of Melphalan and Glutathione S-transferase Polymorphisms in Relation to Side Effects.
- Published in:
- Clinical Pharmacology & Therapeutics, 2008, v. 83, n. 5, p. 749, doi. 10.1038/sj.clpt.6100336
- By:
- Publication type:
- Article
Radioimmunkonjugate: Therapie von Non-Hodgkin-Lymphomen und kolorektalen Karzinomen.
- Published in:
- Der Internist, 2001, v. 42, n. 6, p. 860, doi. 10.1007/s001080170129
- By:
- Publication type:
- Article
Radioimmunkonjugate: Therapie von Non-Hodgkin-Lymphomen und kolorektalen Karzinomen.
- Published in:
- Der Internist, 2001, v. 42, n. 5, p. 860, doi. 10.1007/s001080170129
- By:
- Publication type:
- Article
Evidence for a selected humoral immune response encoded by V<sup>H</sup>4 family genes in the synovial membrane of a patient with rheumatoid arthritis (RA).
- Published in:
- Clinical & Experimental Immunology, 1996, v. 106, n. 1, p. 5, doi. 10.1046/j.1365-2249.1996.d01-806.x
- By:
- Publication type:
- Article
Rhabdomyolysis in allogeneic peripheral blood stem cell donors.
- Published in:
- Vox Sanguinis, 2004, v. 86, n. 4, p. 263, doi. 10.1111/j.0042-9007.2004.00486.x
- By:
- Publication type:
- Article
Radioimmunotherapy for first-line and relapse treatment of aggressive B-cell non-Hodgkin lymphoma: an analysis of 215 patients registered in the international RIT-Network.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 8, p. 1585, doi. 10.1007/s00259-014-2758-y
- By:
- Publication type:
- Article
Retroperitoneal fibrosis as manifestation of chronic GVHD after allogeneic hematopoietic SCT.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 3, p. 467, doi. 10.1038/bmt.2012.165
- By:
- Publication type:
- Article
Radioimmunotherapy with <sup>90</sup>Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Progression of a CD4+/CD56+ blastic plasmacytoid DC neoplasm after initiation of extracorporeal photopheresis in an allogeneic transplant recipient.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Bone marrow side population (SP) cells are donor derived after allogeneic stem cell transplantation in humans.
- Published in:
- 2005
- By:
- Publication type:
- Letter
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2003, v. 32, n. 6, p. 593, doi. 10.1038/sj.bmt.1704192
- By:
- Publication type:
- Article
β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis.
- Published in:
- Carcinogenesis, 2011, v. 32, n. 3, p. 434, doi. 10.1093/carcin/bgq269
- By:
- Publication type:
- Article
Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma—role of radioimmunotherapy.
- Published in:
- Annals of Hematology, 2007, v. 86, n. 2, p. 81, doi. 10.1007/s00277-006-0207-0
- By:
- Publication type:
- Article
Leukemia- and lymphoma-associated genetic aberrations in healthy individuals.
- Published in:
- Annals of Hematology, 2002, v. 81, n. 2, p. 64, doi. 10.1007/s00277-002-0427-x
- By:
- Publication type:
- Article
Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Therapeutic strategies for aggressive lymphomas: the trials of the DSHNHL.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 7, p. 1564, doi. 10.1038/leu.2015.43
- By:
- Publication type:
- Article
Excellent outcome of young adults with aggressive non-Hodgkin lymphomas treated with CHOP-like regimens.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 11, p. 2260, doi. 10.1038/leu.2014.213
- By:
- Publication type:
- Article
Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
- Published in:
- Leukemia (08876924), 2008, v. 22, n. 12, p. 2226, doi. 10.1038/leu.2008.230
- By:
- Publication type:
- Article
Pathway activation patterns in diffuse large B-cell lymphomas.
- Published in:
- Leukemia (08876924), 2008, v. 22, n. 9, p. 1746, doi. 10.1038/leu.2008.166
- By:
- Publication type:
- Article
Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 5, p. 750, doi. 10.1038/sj.leu.2403707
- By:
- Publication type:
- Article
Subgrouping of Burkitt lymphoma variants by DNA methylation is driven by an EBV‐associated epigenotype.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 246, doi. 10.1002/hon.3164_159
- By:
- Publication type:
- Article
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R<sup>2</sup>‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.93_2629
- By:
- Publication type:
- Article
FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 99, doi. 10.1002/hon.64_2629
- By:
- Publication type:
- Article
INTENSIVE IMMUNOCHEMOTHERAPY (R‐CHOEP) VS HIGH‐DOSE IMMUNOCHEMOTHERAPY (R‐MegaCHOEP) IN YOUNG PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA: A 10‐YEAR LONG‐TERM FOLLOW‐UP.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 431, doi. 10.1002/hon.104_2631
- By:
- Publication type:
- Article
SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R<sup>2</sup>‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 132, doi. 10.1002/hon.93_2629
- By:
- Publication type:
- Article
FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 99, doi. 10.1002/hon.64_2629
- By:
- Publication type:
- Article
INTENSIVE IMMUNOCHEMOTHERAPY (R‐CHOEP) VS HIGH‐DOSE IMMUNOCHEMOTHERAPY (R‐MegaCHOEP) IN YOUNG PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA: A 10‐YEAR LONG‐TERM FOLLOW‐UP.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 431, doi. 10.1002/hon.104_2631
- By:
- Publication type:
- Article
Radioimmunotherapy for follicular lymphoma achieves excellent lymphoma control in first line and relapse: 8-year follow-up data of 281 patients from the international RIT-registry.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 361, doi. 10.1002/hon.2439_116
- By:
- Publication type:
- Article
ANTI-INFECTIVE PROPHYLAXIS WITH ACICLOVIR AND COTRIMOXAZOLE SIGNIFICANTLY REDUCES THE RATE OF INFECTIONS AND THERAPY-ASSOCIATED DEATHS IN ELDERLY PATIENTS WITH DLBCL UNDERGOING R-CHOP IMMUNOCHEMOTHERAPY.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 200, doi. 10.1002/hon.2438_63
- By:
- Publication type:
- Article
PROFILING OF DNA METHYLATION IN EPIDEMIOLOGICAL AND CLINICAL SUBGROUPS OF BURKITT LYMPHOMA IN THE FRAMEWORK OF THE MMML: ICGC AND BLUEPRINT CONSORTIA.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 105, doi. 10.1002/hon.2437_94
- By:
- Publication type:
- Article
COMPREHENSIVE EPIGENETIC AND TRANSCRIPTIONAL SURVEY OF THE 'IMPRINTOME' IN NORMAL B-CELLS AND GERMINAL CENTER DERIVED B-CELL LYMPHOMAS OF THE MMML AND ICGC MMML-SEQ NETWORKS.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 155, doi. 10.1002/hon.2438_9
- By:
- Publication type:
- Article